## OSCR: Oscar Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.9% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-7.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($14.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Piper Sandler | $25 | $13 | +92% |
| 2025-11-13 | Wells Fargo | $11 | $14 | -21% |
| 2025-11-10 | Barclays | $13 | $11 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Piper Sandler | up | Overweight |
| 2025-11-13 | Wells Fargo | main | Underweight |
| 2025-11-10 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.09M) |
| Sells | 7 ($1.04M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (+2.1%)
- Blackrock Inc.: 7.1% (+2.7%)
- T. Rowe Price Invest: 3.6% (-34.3%)
- Thrive Capital Manag: 2.8% (0.0%)
- American Century Com: 2.3% (+89.0%)

### Key Risks

1. High beta (1.88) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (13.9%): bears positioning against stock.
3. Near-term weakness: 7.1% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Analyst sentiment positive (2 raises, avg +55%). Insider selling cluster ($1.0M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.8B |
| Beta | 1.88 |
| 52W Range | $11.20 - $23.80 |
| Short Interest | 13.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 4.2% to -2.9% (-7.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >3.0% for momentum thesis). RSI neutral at 50.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.88% (CS: 23) | Weak |
| RSI_14 | 50.2 | Neutral |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.070x | Above |
| vs SMA50 | 0.929x | Below |
| vs SMA200 | 1.042x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $16.73
- **Stop Loss:** $14.39 (14.0% risk)
- **Target:** $19.07 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 213
- **Position Value:** $3,563.49
- **Portfolio %:** 3.56%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-03 (Est: $-0.92)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.58 | $-0.53 | +8.6% |
| 2025Q2 | $-0.84 | $-0.89 | -6.5% |
| 2025Q1 | $0.81 | $0.92 | +13.9% |
| 2024Q4 | $-0.58 | $-0.62 | -6.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*